US 10300095
AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity
granted A61KA61K35/76A61K35/761
Quick answer
US patent 10300095 (AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary, Dept. of Health and Human Services
- Grant date
- Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K35/76, A61K35/761, A61K38/1703, A61K48/005